Trial Profile
A long-term, open-label, safety trial of pregabalin in patients with fibromyalgia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions
- 18 Nov 2005 New trial record.